Evidence map›Paper›PMID 24899142›Full record

ReviewActa neuropathologica2014

Cell fusion in the brain: two cells forward, one cell back.

Kevin Kemp, Alastair Wilkins, Neil Scolding

Open access · hybridAbstract readReview
In one paragraph

Review in Acta neuropathologica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms".International journal of molecular sciences · 2023
    Review
  6. Article
  7. Virus-Induced Membrane Fusion in Neurodegenerative Disorders.Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Tumor Microenvironment and Cell Fusion.BioMed research international · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cell-based therapeutic strategies for multiple sclerosis.Brain : a journal of neurology · 2017
    Review
  15. Article
  16. Review
  17. Functional Mitochondria in Health and Disease.Frontiers in endocrinology · 2017
    Review
  18. Cerebellar Dysfunction in Multiple Sclerosis.Frontiers in neurology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kevin KempMultiple Sclerosis and Stem Cell Group, School of Clinical Sciences, University of Bristol, Neuroscience Office, Learning and Research Building, Southmead Hospital, Bristol, BS10 5NB, UK, kevin.kemp@bristol.ac.uk.
Alastair Wilkins
Neil Scolding
University of Bristol · GBSouthmead Hospital · GB

Funding

Medical Research Council MR/J012580/1Medical Research Council MR/K004166/1
6 · The paper itself

Abstract

Adult stem cell populations, notably those which reside in the bone marrow, have been shown to contribute to several neuronal cell types in the rodent and human brain. The observation that circulating bone marrow cells can migrate into the central nervous system and fuse with, in particular, cerebellar Purkinje cells has suggested, at least in part, a potential mechanism behind this process. Experimentally, the incidence of cell fusion in the brain is enhanced with age, radiation exposure, inflammation, chemotherapeutic drugs and even selective damage to the neurons themselves. The presence of cell fusion, shown by detection of increased bi-nucleated neurons, has also been described in a variety of human central nervous system diseases, including both multiple sclerosis and Alzheimer's disease. Accumulating evidence is therefore raising new questions into the biological significance of cell fusion, with the possibility that it represents an important means of cell-mediated neuroprotection or rescue of highly complex neurons that cannot be replaced in adult life. Here, we discuss the evidence behind this phenomenon in the rodent and human brain, with a focus on the subsequent research investigating the physiological mechanisms of cell fusion underlying this process. We also highlight how these studies offer new insights into endogenous neuronal repair, opening new exciting avenues for potential therapeutic interventions against neurodegeneration and brain injury.

Indexed as

Cell FusionAdult Stem CellsAnimalsBrainHumansNeurons

Identifiers

PMID24899142
PMCPMC4201757
OpenAlexW1963945591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.